Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: A multivariate analysis of a Swedish COPD cohort

European Journal of Health Economics

Volumn 10, Issue 2, 2009, Pages 217-226

  Gerdtham, Ulf Göran ^a,b   Andersson, L Fredrik ^c,d   Ericsson, Åsa ^c   Borg, Sixten ^e   Jansson, Sven Arne ^f,g   Rönmark, Eva ^f,g   Lundbäck, Bo ^f,g  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^f SUNDERBY HOSPITAL   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chronic obstructive pulmonary disease; Cost drivers; Costs; Multivariate explanatory model

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST OF ILLNESS; DISEASE SEVERITY; DYSPNEA; FEMALE; HEALTH CARE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

AGED; COHORT STUDIES; FEMALE; HEALTH EXPENDITURES; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SWEDEN;

EID: 63449112295     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-008-0121-6     Document Type: Article

References (32)

1. CJL Murray AD Lopez 1999 Evidence-based health policy-lessons from the Global Burden of Disease Study Science 274 740 743
2. ME Grasso WE Weller TJ Shaffer GB Diette GF Anderson 1998 Capitation, managed care and chronic obstructive pulmonary disease Am. J. Respir. Crit. Care. Med. 158 133 138
3. S-A Jansson F Andersson S Borg Å Ericsson E Jönsson B Lundbäck 2002 Costs of COPD in Sweden according to disease severity Chest 122 1994 2002
4. DW Mapel JS Hurley FJ Frost HV Petersen MA Picchi DB Coultas 2000 Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization Arch. Intern. Med. 160 2653 2658
5. MPMH Rutten van Mölken MJ Postma MA Joore MLL van Genugten R Ledl JC Jager 1999 Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands Resp. Med. 93 779 787
6. SA Strassels DH Smith SD Sullivan PS Mahajan 2001 The costs of treating COPD in the United States Chest 119 344 352
7. AJ Crockett JM Cranston JR Moss JH Alpers 2000 An association between length of stay and co-morbidity in chronic airflow limitation Int. J. Qual. Health Care 12 41 46
8. B Alemayehu RE Aubert RA Feifer LD Paul 2002 Comparative analysis of two quality-of-life instruments for patients with chronic obstructive pulmonary disease Value Health 5 437 442
9. 1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease Eur. Respir. J. 2 710 715
10. DE Hilleman EC Wadibia B Shinn 1995 Pharmacoeconomic evaluation of COPD: stratification of outcomes and costs according to initial drug therapy Pharmacotherapy 15 3 A386
11. F Andersson S Borg S-A Jansson A-C Jonsson Å Ericsson C Prütz E Rönmark B Lundbäck 2002 The costs of exacerbations in chronic obstructive pulmonary disease (COPD) Resp. Med. 96 700 708
12. HS Ruchlin EJ Dasbach 2001 An economic overview of chronic obstructive pulmonary disease Pharmacoeconomics 19 623 642
13. Lundbäck, B.: Asthma, chronic bronchitis and respiratory symptoms: prevalence and important determinants. The Obstructive Lung Disease in Northern Sweden Study I. Umeå University Medical Dissertation, Umeå (1993)
14. Rönmark, E.: Asthma-incidence, remission and risk factors. The Obstructive Lung Disease in Northern Sweden Study II. Umeå University Medical Dissertation, Umeå (1999)
15. British Thoracic Society 1997 BTS guidelines for the management of chronic obstructive pulmonary disease Thorax 52 S5 1s 28s
16. RA Pauwels AS Buist PM Calverley CR Jenkins SS Hurd 2001 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am. J. Respir. Crit. Care Med. 163 1256 1276
17. HA White 1980 Heteroscedasticity-consistent covariance matrix estimator and a direct test for heteroscedasticity Econometrica 48 817 838
18. CM Jarque AK Bera 1987 A test for normality of observations and regression residuals Int. Stat. Rev. 55 163 172
19. Kmenta, J.: Elements of econometrics, 2nd edn. MacMillan, New York (1986)
20. JC Bestall EA Paul R Garrod R Garnham PW Jones JA Wedzicha 1999 Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 581 586
21. PW Jones FH Quirk CM Baveystock P Littlejohns 1992 A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire Am. Rev. Resp. Dis. 146 1321 1327
22. Kind, P.: The EuroQoL instrument: an index of health-related quality of life (chapter 22). In: Spilker, B. (ed.) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia (1996)
23. EFM Wouters 2003 Economic analysis of the confronting COPD survey: an overview of results Resp. Med. 97 Suppl. C S3 S14
24. Folland, S., Goodman, A.C., Stano, M.: The economics of health and health care, 3rd edn. Prentice-Hall, Upper Saddle River (2001)
25. MI Roemer 1961 Bed supply and hospital utilization: a national experiment Hospitals JAHA 35 988 993
26. R Dankner U Goldbourt V Boyko H Reicher-Reiss 2003 Predictors of cardiac and noncardiac mortality among 14, 687 patients with coronary heart disease Am. J. Cardiol. 91 121 127
27. DW Mapel GP McMillan FJ Frost JS Hurley MA Picchi E Lydick MD Spencer 2005 Predicting the cost of managing patients with chronic obstructive pulmonary disease Resp. Med. 99 1325 1333
28. J Garcia-Aymerich E Monso RM Marrades J Escarrabill MA Félez J Sunyer 2001 Risk factors for hospitalization for chronic obstructive pulmonary disease exacerbation Am. J. Respir. Crit. Care Med. 164 1002 1007
29. M Decramer R Gosselink T Troosters M Verschueren G Evers 1997 Muscle weakness is related to utilization of health care resources in COPD patients Eur. Respir. J. 10 417 423
30. R Kessler M Faller G Fourgaut B Mennecier E Weitzenbaum 1999 Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 159 158 164
31. JB Oostenbrink MPMH Rutten-van Mölken 2004 Resource use and risk factors in high-cost exacerbations of COPD Resp. Med. 98 883 891
32. S Borg Å Ericsson J Wedzicha A Gulsvik B Lundbäck GC Donaldson SD Sullivan 2004 A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease Value Health 7 153 167